Staff reporter
,
South Korea
Photo by Nwato
The country accounts for 8% of the Mycobacterium tuberculosis testing industry in the Asia-Pacific region this year.
Rising incidence of tuberculosis (TB) and advances in molecular diagnostics are driving the Korean mycobacterial diagnostic testing market and is expected to expand at a CAGR of 3% through 2034.
A report from GlobalData shows that South Korea accounts for approximately 8% of the Mycobacterium tuberculosis testing market in the Asia-Pacific region this year.
“Advances in molecular diagnostics that enable faster and more accurate detection of drug-resistant TB strains are critical to curbing the spread of XDR-TB and improving patient outcomes,” said Jyoti Sharma, Medical Devices Analyst at GlobalData.
In a recent development, South Korea’s SD Biosensor, Inc. collaborates with the Japan Tuberculosis Research Institute, a subsidiary of the Japan Anti-Tuberculosis Association, and the Korea International Tuberculosis Research Center.
Through the tripartite MoU, the partners will focus on developing advanced molecular diagnostic solutions for extensively drug-resistant tuberculosis.
“Such innovations and collaborations are critical to meeting the challenges posed by drug-resistant tuberculosis,” Sharma added.
Join the Asian Healthcare Magazine Community
Now that you’re here…
….There are many ways you can work with us to promote your company and connect with your customers. Our team can help you plan and create print and digital advertising campaigns on this website and in the print magazine.
We can also organize real-life or digital events for you and source thought-leader speakers and industry leaders (who may be your potential partners) to attend your events. We also run a number of awards programs that give you the opportunity to be recognized for your achievements during the year, and you can join as a participant or sponsor.
Let us help you drive business development through good partnerships!
